# US 2020/0190505 A1 · Acrylamide copolymerization for sequestration and production of single-stranded nucleic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2020/0190505 A1
- Document ID: US20200190505A1
- Status: Published application
- Kind: A1
- Application number: 16/332,674
- Filed: 2017-09-11
- Published: 2020-06-18
- Earliest claimed: 2016-09-12
- Assignees: Dana-Farber Cancer Institute, Inc.
- Applicants: Dana-Farber Cancer Institute, Inc.
- Inventors: Elisha Krieg; William M. Shih
- Web page: https://patentgrep.com/patent/US20200190505A1

## CPC

- C12N 15/1006: {by means of a solid support carrier, e.g. particles, polymers}
- C12N 15/111: {General methods applicable to biologically active non-coding nucleic acids}
- C08F 220/56: Acrylamide; Methacrylamide
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12N 15/1017: {by filtration, e.g. using filters, frits, membranes}
- C12Q 1/6806: Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay (C12Q1/6804 takes precedence)
- C08J 2333/26: Homopolymers or copolymers of acrylamide or methacrylamide
- C12N 2310/00: Structure or type of the nucleic acid
- C12N 2330/30: chemically synthesised
- C12Q 2523/305: Denaturation or renaturation by physical action
- C12Q 2523/32: Centrifugation
- C12Q 2525/204: specific length of the oligonucleotides
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C08F: MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C08J: WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H (working, e.g. shaping, of plastics B29)

## Abstract

Provided herein, in some embodiments, are methods, compositions and kits for large-scale production of long single-stranded DNA in solution.

## Claims

### Claim 1

A method of producing single-stranded deoxyribonucleic acid (ssDNA), comprising:
(a) combining in solution acrylamide-labeled double-stranded deoxyribonucleic acid (dsDNA) and acrylamide (AA) monomers to form copolymer-linked dsDNA; and
(b) dehybridizing the copolymer-linked dsDNA to produce in solution free ssDNA and DNA-containing copolymer; and
(c) separating the free ssDNA from the solution of (b).

### Claim 2 (depends on 1)

The method of claim 1 further comprising separating the free ssDNA from the solution of (b).

### Claim 3 (depends on 1, 2)

The method of claim 1 or 2, wherein the length of the double-stranded nucleic acid is at least 100 nucleotide base pairs.

### Claim 4 (depends on 3)

The method of claim 3, wherein the length of the double-stranded nucleic acid is 100-10,000 nucleotide base pairs.

### Claim 5 (depends on 4)

The method of claim 4, wherein the length of the double-stranded nucleic acid is 100-50,000 nucleotide base pairs.

### Claim 6 (depends on 1, 2, 3, 4, 5)

The method of any one of claims 1-5, wherein the concentration of acrylamide monomers in the solution is 10-100 mg/ml.

### Claim 7 (depends on 6)

The method of claim 6, wherein the concentration of acrylamide monomers in the solution is 50 mg/ml.

### Claim 8 (depends on 1, 2, 3, 4, 5, 6, 7)

The method of any one of claims 1-7, wherein the concentration of acrylamide-labeled dsDNA in the solution is 0.01-10 mg/ml.

### Claim 9 (depends on 8)

The method of claim 8, wherein the concentration of acrylamide-labeled dsDNA in the solution is 1 mg/ml.

### Claim 10 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9)

The method of any one of claims 1-9, wherein the solution comprises ammonium persulfate (APS) and tetramethylethylenediamine (TEMED).

### Claim 11 (depends on 9, 10)

The method of claim 9 or 10, wherein the solution comprises ammonium persulfate at a concentration of 0.01 wt %-0.05 wt %.

### Claim 12 (depends on 9, 10)

The method of claim 9 or 10, wherein solution comprises tetramethylethylenediamine at a concentration of 0.01 wt %-0.05 wt %.

### Claim 13 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12)

The method of any one of claims 1-12, wherein the solution further comprises acrylate (A).

### Claim 14 (depends on 13)

The method of claim 13, wherein the ratio of AA:A is at least 99:1.

### Claim 15 (depends on 13)

The method of claim 13, wherein the ratio of AA:A is 50:1 to 200:1.

### Claim 16 (depends on 14, 15)

The method of claim 14 or 15, wherein the ratio of AA:A is 99:1.

### Claim 17 (depends on 13, 14, 15, 16)

The method of any one of claims 13-16 further comprising incubating the solution of (a) for 1-3 hours.

### Claim 18 (depends on 17)

The method of claim 17, wherein the copolymer-linked dsDNA comprises a linear copolymer.

### Claim 19 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein the solution comprises ammonium persulfate at a concentration of 0.0005 wt %-0.002 wt %.

### Claim 20 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10)

The method of any one of claims 1-10, wherein solution comprises tetramethylethylenediamine at a concentration of 0.0005 wt %-0.002 wt %.

### Claim 21 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 19, 20)

The method of any one of claim 1-10, 19 or 20, wherein the solution further comprises a crosslinking agent.

### Claim 22 (depends on 21)

The method of claim 21, wherein the crosslinking agent comprises bisacrylamide (BAA), piperazine diacrylamide, N,N′(Hexamethylenebis(methacrylamide), N,N′-ethylenebis(acrylamide), or combinations thereof.

### Claim 23 (depends on 22)

The method of claim 22, wherein the BAA comprises N,N′-methylenebisacrylamide.

### Claim 24 (depends on 22, 23)

The method of claim 22 or 23, wherein the ratio of AA:BAA in the solution is less than 100:1.

### Claim 25 (depends on 24)

The method of claim 24, wherein the ratio of AA:BAA in the solution is less than 10:1.

### Claim 26 (depends on 25)

The method of claim 25, wherein the ratio of AA:BAA in the solution is 9:1 to 1:1.

### Claim 27 (depends on 21, 22, 23, 24, 25, 26)

The method of any one of claims 21-26 further comprising incubating the solution of (a) for at least 8 hours.

### Claim 28 (depends on 27)

The method of claim 27, wherein the copolymer-linked dsDNA comprises a crosslinked copolymer.

### Claim 29 (depends on 28)

The method of claim 28, wherein the crosslinked copolymer has a molecular weight of at least 1 kDa, at least 10 kDa, at least 100 kDa or at least 1000 kDa.

### Claim 30 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)

The method of any one of claims 1-29, wherein the copolymer-linked dsDNA comprises at least 80% of the acrylamide-labeled dsDNA from the solution.

### Claim 31 (depends on 30)

The method of claim 30, wherein the copolymer-linked dsDNA comprises at least 90% of the acrylamide-labeled dsDNA.

### Claim 32 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31)

The method of any one of claims 1-31, wherein the solution comprises contaminants.

### Claim 33 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)

The method of any one of claims 1-32 further comprising purifying the copolymer-linked dsDNA from the solution of (a).

### Claim 34 (depends on 33)

The method of claim 33, wherein the purifying comprises adding methanol to the solution of (a) to selectively precipitate purified copolymer-linked dsDNA.

### Claim 35 (depends on 34)

The method of claim 34, wherein the purifying comprises adding at least two volumes of methanol to the solution of (a), relative to the volume of the solution of (a), to selectively precipitate purified copolymer-linked dsDNA.

### Claim 36 (depends on 34, 35)

The method of claim 34 or 35 further comprising removing the purified copolymer-linked dsDNA from the solution of (a) and redispersing the purified copolymer-linked dsDNA in an aqueous buffer.

### Claim 37 (depends on 33)

The method of claim 33, wherein the purifying comprises loading the copolymer-linked dsDNA from the solution of (a) into a well of an agarose gel, applying an electric current to the gel to elute contaminants into the agarose gel, and isolating purified copolymer-linked dsDNA from the agarose gel.

### Claim 38 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37)

The method of any one of claims 1-37, wherein the dehybridizing of (b) comprises combining the copolymer-linked dsDNA with an aqueous buffer comprising (i) sodium hydroxide and ethylenediaminetetraacetic acid (EDTA), (ii) formamide and EDTA, or (iii) Tris-EDTA.

### Claim 39 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The method of any one of claims 1-38, wherein the separating comprises adding methanol to the solution of (b) to selectively precipitate the DNA-containing copolymer, thereby producing a retrieval solution comprising DNA-containing copolymer precipitate and free ssDNA.

### Claim 40 (depends on 39)

The method of claim 39, wherein the separating comprises adding at least two volumes of methanol to the solution of (b), relative to the volume of the solution of (b), to selectively precipitate the DNA-containing copolymer, thereby producing a retrieval solution comprising DNA-containing copolymer precipitate and free ssDNA.

### Claim 41 (depends on 39, 40)

The method of claim 39 or 40 further comprising removing the DNA-containing copolymer precipitate from the retrieval solution, and isolating the free ssDNA from the retrieval solution.

### Claim 42 (depends on 41)

The method of claim 41, wherein the isolating comprises adding ethanol or isopropanol to the retrieval solution to precipitate the free ssDNA.

### Claim 43 (depends on 42)

The method of claim 42, wherein the isolating results in an at least 70% yield of free ssDNA precipitated from the retrieval solution.

### Claim 44 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The method of any one of claims 1-38, wherein the DNA-containing copolymer comprises crosslinked DNA-containing copolymer, and wherein the separating comprises passing the retrieval solution over a microfiltration membrane to remove the crosslinked DNA-containing copolymer.

### Claim 45 (depends on 44)

The method of claim 44, wherein the microfiltration membrane is a cellulosed acetate membrane or a polyethersulfone membrane.

### Claim 46 (depends on 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38)

The method of any one of claims 1-38, wherein the DNA-containing copolymer comprises crosslinked DNA-containing copolymer, and wherein the separating comprises subjecting the retrieval solution to centrifugation to remove the crosslinked DNA-containing copolymer.

### Claim 47 (depends on 46)

The method of claim 46, wherein the centrifugation is ultracentrifugation at a speed of 100000-200000 g for 15-60 minutes.

### Claim 48 (depends on 44, 45, 46, 47)

The method of claim any one of claims 44-47 further comprising isolating the free ssDNA from the retrieval solution.

### Claim 49 (depends on 48)

The method of claim 48, wherein the isolating comprises adding ethanol or isopropanol to the retrieval solution to precipitate the free ssDNA.

### Claim 50 (depends on 49)

The method of claim 49, wherein the isolating results in an at least 70% yield of free ssDNA precipitated from the retrieval solution.

### Claim 51

A method of target capture, comprising:
combining, in solution comprising a target nucleic acid, acrylamide-labeled oligonucleotides having a nucleotide sequence complementary to a nucleotide sequence of the target nucleic acid, to form a captured target nucleic acid; and
separating the captured target nucleic acid from the solution.

### Claim 52

A method of target capture, comprising:
combining, in solution comprising a target linked to a oligonucleotide label, acrylamide-labeled oligonucleotides having a nucleotide sequence complementary to a nucleotide sequence of the oligonucleotide label, to form a captured target; and
separating the captured target from the solution.

### Claim 53 (depends on 51, 52)

The method of claim 51 or 52, wherein the target is a protein.

### Claim 54

A kit comprising:
acrylamide monomers;
ammonium persulfate (APS);
tetramethylethylenediamine (TEMED); and
methanol.

### Claim 55 (depends on 54)

The kit of claim 54 further comprising acrylamide-labeled nucleic acid.

### Claim 56 (depends on 55)

The kit of claim 55, wherein the nucleic acid is single-stranded oligonucleotide or double-stranded deoxyribonucleic acid (dsDNA).

### Claim 57 (depends on 54, 55, 56)

The kit of any one of claims 54-56 further comprising methylenebisacrylamide (BAA) and/or acrylate (A).

### Claim 58 (depends on 54, 55, 56, 57)

The kit of any one of claims 54-57 further comprising an aqueous buffer.

### Claim 59 (depends on 54, 55, 56, 57, 58)

The kit of any one of claims 54-58 further comprising (i) sodium hydroxide and ethylenediaminetetraacetic acid (EDTA), (ii) formamide and EDTA, or (iii) Tris-EDTA.

### Claim 60 (depends on 54, 55, 56, 57, 58, 59)

The kit of any one of claims 54-59 further comprising ethanol or isopropanol.

### Claim 61 (depends on 54, 55, 56, 57, 58, 59, 60)

The kit of any one of claims 54-60 further comprising a microfiltration membrane.

### Claim 62 (depends on 61)

The kit of claim 61, wherein the microfiltration membrane is a cellulosed acetate membrane or a polyethersulfone membrane.

### Claim 63 (depends on 54, 55, 56, 57, 58, 59, 60, 61, 62)

The kit of any one of claims 54-62 further comprising centrifuge tubes and/or a syringe needle.

### Claim 64

An aqueous composition comprising:
a crosslinked copolymer having a molecular weight of at least 1000 kDa and linked to nucleic acids; and
acrylamide (AA) and bisacrylamide (BAA), wherein the ratio of AA:BAA in the aqueous composition is less than 100:1.

### Claim 65

An aqueous composition comprising:
a linear copolymer comprising acrylamide and acrylamide-labeled double-stranded deoxyribonucleic acid (dsDNA) having a length of at least 1000 nucleotide base pairs.
